We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Getting the measure of the pressure: Optimal assessment of the effects of glucagon‐like peptide‐1 receptor agonists on blood pressure.
- Authors
Jones, Karen L.; Marathe, Chinmay S.; Wu, Tongzhi; Rayner, Christopher K.; Nauck, Michael; Horowitz, Michael
- Abstract
The article discusses the effects of glucagon-like peptide-1 (GLP-1) receptor agonists on blood pressure. GLP-1 receptor agonists have been shown to have cardiovascular and renal protective effects, independent of their glucose-lowering properties. While these drugs have been found to reduce systolic blood pressure in hypertensive individuals, they have little effect on diastolic blood pressure or normotensive individuals. The article also highlights the importance of accurately measuring blood pressure, including postprandial blood pressure, and suggests that further research is needed to optimize the assessment of the effects of GLP-1 receptor agonists on blood pressure.
- Subjects
GLUCAGON-like peptide-1 receptor; GASTRIC emptying; BLOOD pressure; GLUCAGON-like peptide-1 agonists; HEALTH facilities; DIASTOLIC blood pressure
- Publication
Diabetes, Obesity & Metabolism, 2024, Vol 26, Issue 8, p3003
- ISSN
1462-8902
- Publication type
Article
- DOI
10.1111/dom.15631